Preliminary results from a phase 2 trial of tipifarnib in HRAS-mutant head and neck squamous cell carcinomas Meeting Abstract


Authors: Ho, A.; Chau, N.; Brana Garcia, I.; Ferte, C.; Even, C.; Burrows, F.; Kessler, L.; Mishra, V.; Magnuson, K.; Scholz, C.; Gualberto, A.
Abstract Title: Preliminary results from a phase 2 trial of tipifarnib in HRAS-mutant head and neck squamous cell carcinomas
Meeting Title: 2018 Multidisciplinary Head and Neck Cancers Symposium
Journal Title: International Journal of Radiation Oncology, Biology, Physics
Volume: 100
Issue: 5
Meeting Dates: 2018 Feb 15-17
Meeting Location: Scottsdale, AZ
ISSN: 0360-3016
Publisher: Elsevier Inc.  
Date Published: 2018-04-01
Start Page: 1367
Language: English
ACCESSION: WOS:000428145600180
PROVIDER: wos
DOI: 10.1016/j.ijrobp.2017.12.156
Notes: Meeting Abstract: 217 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alan Loh Ho
    237 Ho